87 results about "Cerebral atrophy" patented technology

The present invention discloses an Alzheimer's disease auxiliary therapeutic device utilizing high potential and ultrashort wave and belongs to the technical field of Alzheimer's disease therapy. TheAlzheimer's disease auxiliary therapeutic device utilizing the high potential and ultrashort wave comprises a high potential therapy mechanism, a left side of the high potential therapy mechanism is provided with a therapy chair, an upper end of the high potential therapy mechanism is fixedly connected with an operation console, the operation console is provided with a potential adjusting panel, and the potential adjusting panel is electrically connected with the operation console. The Alzheimer's disease auxiliary therapeutic device can realize combination of a high potential therapy with anultrashort wave therapy for the Alzheimer's disease therapy, improves a healing effect of Alzheimer's diseases, regulates signal transmission of neurons, and reduces and alleviates occurrence and development of brain atrophy. At the same time, a magnetic therapy reflection mechanism is arranged to speed up therapy efficiency of the adjuvant therapeutic device, reduces time spent on ultrashort wavetherapy for a long time, and thus reduces discomfort of patients during the therapy.

The invention relates to a traditional Chinese medicine preparation for treating senile dementia, encephalatrophy and dysgnosia. The traditional Chinese medicine preparation is prepared from the following substances in parts by weight: pilos antler, saffron crocus, astragalus membranaceus, herba cistanche, earthworms, turtle paste, hirudo, golden cypress, semen cuscutae, morinda officinalis, salvia miltiorrhiza, ligusticum wallichii, tail of Chinese angelica root, peach kernels, radix paeoniae rubra, dipsacaceae, radix achyranthis bidentatae, rhodiola rosea, polygala tenuifolia, radix angelicae, notoginseng, safflower carthamus, caulis spatholobi, rhizoma drynariae, epimedium and rehmannia glutinosa. According to the traditional Chinese medicine preparation, the cognition impairment can be improved, the cerebral atrophy can be delayed, the memory can be increased, and an obvious effect of preventing and treating the senile dementia is achieved.

The invention belongs to the technical field of traditional Chinese medicine, and relates to a traditional Chinese medicine preparation agent for regulating high cholesterol. The medicine is prepared by parts from puer tea, lindera aggregate, cyperus rotundus, melon kwai, creat, fructus forsythia, hawksbill, radix asparagi, pollen typhae, pubescent holly root, gastrodia elata, and kelp. The present invention combines traditional remedy with conclusions from many years' clinical experiences, after repeated experiments to be prepared ready, therefore, the present medicine has unique remedy effect for refractory high cholesterol, it adopts multiple medicines scientifically proportioned, together with treatments enables the effective components of medicine to rapidly enter into blood circulation, lowers the blood cholesterol, prevents thrombus formation, enlarges coronary artery, increases blood flow, increases the endurance ability of blood muscle ischemia, improves cerebral infarction, repairs damaged brain nerves, enabling fast recovery of high blood lipid. The medicine has unique remedy effect for patients with high-blood pressure, high blood fat, diabetes, encephalatrophy, cerebral thrombosis, coronary heart disease, cerebral arteriosclerosis, sequela of apoplexy. The medicine has the advantages of being fast in taking effect, short in treatment period, high in recovery rate, and low in expenses.

The invention relates to a medicinal preparation for treating cerebral palsy. The medicinal preparation provided by the invention has the function of benefiting brain and restoring mental clarity, is mainly used for treating cerebral palsy, amentia, hyperactivity, senile dementia and the like, and has remarkable effect in treating diseases caused by cerebral dysplasia, encephalatrophy and the like. The medicinal preparation is simple in preparation process, convenient in production processing, and definite in therapeutic effect.

The invention relates to a traditional Chinese medicine for treating acute cerebral infarction. The traditional Chinese medicine is prepared from curcuma aromatic, raw pollen typhae, rhizoma corydalis, winged euonymus twig, snakegourd fruit, costusroot, coptis chinensis, schisandra chinensis, pubescent holly root, bile arisaema, panax notoginseng, gentiana macrophylla, radix codonopsis, dragon bone, semen plantaginis, red peony root, herba taxilli, rosa laevigata michx, fructus rubi and resina draconis. The traditional Chinese medicine is obtained by the inventor by combining with summaries of clinical experience over the years through repeated experiments on the basis of the secret prescription handed down from ancestors, so that the traditional Chinese medicine has a unique curative effect on an intractable 'cerebral infarction' disease; and the effective components of the medicine can rapidly enter blood circulation by scientific combination and comprehensive treatment of a plurality of medicines, so that blood cholesterol is reduced; thrombogenesis is blocked up; a coronary artery is expanded; the blood flow is increased; the tolerance of brain ischemia is improved; cerebral infarction is improved; damaged cranial nerves are repaired; and the 'cerebral infarction' disease can be rapidly cured. The traditional Chinese medicine has a unique curative effect on hypertension, hyperlipidemia, encephalanalosis, cerebral thrombosis, coronary heart diseases, cerebral arteriosclerosis and sequela of apoplexy, and has the advantages of being fast in acting, short in treatment course, high in recovery rate and low in cost.

A brain health food / brain health beverage for preventing / alleviating brain atrophy due to alcohol intake is developed. The brain health food or brain health beverage containing, as active ingredients,folic acid, vitamin B6, and vitamin B12, for preventing a decrease in the brain capacity of regular drinkers who are not suffering from dementia, i.e., healthy people, is characterized by containing,as active ingredients, 0.4-0.8 mg of folic acid, 10-20 mg of vitamin B6, and 0.25-0.5 mg of vitamin B12.

The invention discloses a Chinese medicinal preparation for treating encephalatrophy, which is prepared from the following raw materials in part by weight: 35 to 80 parts of fatsia japonica, 30 to 75 parts of arisaema inkiangense, 80 to 120 parts of astragalus, 30 to 75 parts of white paeony root, 20 to 70 parts of Chinese angelica, 15 to 65 parts of radix achyranthe bidentatae, 5 to 70 parts of tuber fleeceflower root, 20 to 70 parts of earthworm and 10 to 40 parts of ground beetle. The Chinese medicinal preparation for treating the encephalatrophy has the effects of tonifying liver and kidney, reinforcing vital energy, regulating Yin-Yang, dilating blood vessels, improving blood supply, recovering elasticity of blood vessels of brain, improving blood circulation and recovering functions of atrophic brain cells. Generally, the capsule has 100 percent of effective rate and 92 percent of cure rate within 60 days after being taken by patients with the encephalatrophy.

The invention relates to a Chinese medicinal composition Naohuandan for treating encephalatrophy, cerebral hemorrhage, cerebral infarction, senile dementia and Parkinson syndrome. The Chinese medicinal composition is prepared from the following Chinese herbal medicines by weight: 250g of honeycomb, 15g of gambir plant, 15g of tall gastrodia tuber, 20g of puncturevine caltrop fruit, 15g of montmorillonite, 10g of dragon bone, 20g of root of red-rooted salvia, 10g of Szechuan lovage rhizome and 20g of astragalus.